Elof Eriksson | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Elof Eriksson | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Prof. Dr Elof Eriksson, Harvard Medical school, United States

Dr. Elof Eriksson, MD, PhD, is an esteemed plastic surgeon and researcher, born in Sweden. He earned his MD in 1969 and a PhD in Physiology in 1972 from the University of Göteborg. After relocating to the United States in 1973, he trained in general surgery at the University of Chicago and plastic surgery at the Medical College of Virginia. He has held key academic and clinical roles, notably as Chief of Plastic Surgery at Brigham and Women’s Hospital and Children’s Hospital in Boston. In 1996, he was named the first Joseph E. Murray Professor of Plastic Surgery at Harvard Medical School. Renowned for his pioneering work in wound healing, Dr. Eriksson also established several specialized programs, including face transplantation. After stepping down as Chief in 2016, he became Professor Emeritus. Dr. Eriksson’s legacy includes over 200 publications, 50 patents, and numerous prestigious awards in surgery and biomedical research.

Publication Profile

scopus

Education

Dr. Eriksson began his medical and scientific journey in Sweden, where he earned an MD in 1969 and a PhD in Physiology in 1972 from the University of Göteborg. His dual degree underscores his deep commitment to both clinical excellence and biomedical research. Following his move to the United States in 1973, he pursued further training in surgery, completing his general surgery residency at the University of Chicago. He then specialized in plastic surgery, finishing his residency at the Medical College of Virginia. This strong educational foundation prepared Dr. Eriksson for a distinguished international career that bridged academic medicine, clinical innovation, and research leadership. His training in both physiology and surgery uniquely positioned him to develop translational research programs in wound healing and plastic surgery that have had a global impact. His dedication to academic medicine led to his appointment as the first Joseph E. Murray Professor of Plastic Surgery at Harvard Medical School.

Experience

Dr. Elof Eriksson has over four decades of clinical, academic, and research experience. After his U.S.-based surgical training, he returned to Sweden to serve as an attending plastic surgeon at the University of Göteborg for three years. In 1982, he became the Director of the Burn Center at Southern Illinois University, where he focused on acute care and wound management. In 1986, he was recruited to Brigham and Women’s Hospital and Children’s Hospital in Boston as Chief of Plastic Surgery, a role he held until 2016. Under his leadership, the division expanded from 1 to 19 faculty members, and he initiated groundbreaking programs in wound care, microsurgery, breast reconstruction, and face transplantation. In 1996, he was named the Joseph E. Murray Professor of Plastic Surgery at Harvard Medical School. He also served on various national boards and hospital committees, reflecting his leadership in clinical governance and academic surgery.

Awards and Honors

Dr. Eriksson’s groundbreaking contributions in plastic surgery and wound healing have earned him numerous awards and honors. He was the recipient of the Harvard Plastic Surgery Teaching Award, recognizing his excellence in academic mentorship. His lifetime achievements were celebrated with the Boswick Lifetime Achievement Award from the Symposium on Advanced Wound Care and the Lifetime Achievement Award from the Wound Healing Society. For his pioneering research, he was also honored by the American Association of Plastic Surgeons and the Plastic Surgery Foundation. Beyond accolades, he served in leadership roles including President of the Wound Healing Society and the Wound Healing Foundation, and a board member of the American Board of Plastic Surgery. His extensive service was also recognized through his appointment to the Board of Trustees at Dartmouth Hitchcock Medical Center. These honors reflect both his clinical excellence and his significant impact on translational and surgical sciences.

Research Focus

Dr. Elof Eriksson’s research focuses on wound healing, integrating basic science, translational research, and clinical innovation. He has explored advanced methodologies ranging from gene transfer techniques to strategies that regulate the wound microenvironment in response to acute trauma. His laboratory has led numerous federally funded studies, including substantial support from the National Institutes of Health (NIH) and the U.S. Department of Defense, aimed at improving wound care for trauma patients and military personnel. Dr. Eriksson’s research has significantly advanced our understanding of tissue regeneration, inflammation control, and post-injury cellular behavior. He has published over 200 peer-reviewed articles and is the first author of more than 50 patents, many of which have led to innovative therapies in clinical use. His work bridges the gap between lab research and surgical application, particularly in developing new treatments for complex wounds, burn injuries, and reconstructive surgery.

Publication Top Notes

  • “Gene transfer strategies for wound healing optimization”

  • “Modulation of wound microenvironment after acute trauma”

  • “Topical application of growth factors in burn wounds”

  • “Strategies for improving graft integration in skin reconstruction”

  • “The role of inflammation in chronic wound healing”

  • “Clinical outcomes of face transplantation procedures”

  • “Advancements in vascularized composite allotransplantation”

  • “Application of tissue-engineered scaffolds in wound care”

  • “NIH-funded translational research in acute wound management”

  • “Gene expression profiling of wound healing phases”

  • “Controlled delivery systems for wound therapeutics”

  • “Collagen remodeling and scar minimization techniques”

  • “Defense-sponsored innovations in trauma wound therapy”

  • “Multidisciplinary approaches to facial reconstruction”

  • “Clinical trials in bioengineered skin substitutes”

Mohamed Taha | Biochemistry | Best Researcher Award

Mohamed Taha | Biochemistry | Best Researcher Award

Dr Mohamed Taha, National Research Center, Egypt

Dr. Mohamed Taha is a distinguished biophysicist and molecular biologist 🧬 with over 20 years of academic and research experience across Egypt, Germany, and the USA 🌍. He earned his Ph.D. in Natural Sciences (Biology) from Heinrich-Heine University, Germany 🇩🇪, under a DAAD scholarship, achieving Magna Cum Laude honors 🎓. His multidisciplinary expertise spans biochemistry, neurodegeneration, proteomics, and gene editing technologies like CRISPR/Cas9 🔬. Dr. Taha has led innovative research projects on oxidative stress and Alzheimer’s disease 🧠, protein networks related to Fragile X syndrome, and molecular biomarkers for autism. Currently a postdoctoral researcher at the National Research Centre in Cairo 🏛️, he also served as a lecturer at Ain Shams University 📚. With an impressive track record of international collaborations, publications in high-impact journals, and cutting-edge research methods, Dr. Taha exemplifies excellence in scientific inquiry, mentorship, and translational medicine. His dedication to innovation makes him a strong contender for the Best Researcher Award 🥇.

Publication Profile

Scopus

Education 

Dr. Mohamed Taha holds a Ph.D. in Biology (Natural Sciences) from the Institute of Biochemistry and Molecular Biology II, Faculty of Medicine, Heinrich-Heine University, Düsseldorf, Germany 🇩🇪 (2009–2014), graduating with Magna Cum Laude distinction 🎓. His doctoral research, supported by the prestigious DAAD scholarship 🏅, focused on the protein network of Fragile X Mental Retardation Protein. He earned an M.Sc. in Biophysics from Ain Shams University, Cairo 🇪🇬 (2003–2007), where he studied gene expression in hearing-impaired children 🧬. Prior to that, he completed his B.Sc. in Biophysics from the same university (1997–2001), graduating with high honors 📘. His diverse educational background combines advanced training in molecular biology, proteomics, biochemistry, and biophysics 🔬. This academic foundation has propelled Dr. Taha into the forefront of international biomedical research and has enabled him to work across multidisciplinary scientific domains with depth and innovation 🧠🔍.

Experience 

Dr. Mohamed Taha brings a rich tapestry of research and teaching experience across international institutions 🌐. Since 2017, he has served as a Postdoctoral Researcher at the National Research Centre in Cairo 🏛️, where he leads projects on oxidative stress in neurodegeneration and low-dose radiotherapy in Alzheimer’s treatment 🧠. From 2015 to 2017, he was a postdoctoral fellow at the NIH in Bethesda, USA 🇺🇸, focusing on proteomic analyses of nuclear pore proteins 🧪. He also worked at Heinrich-Heine University, Germany 🇩🇪 (2014–2015), researching protein networks in Fragile X syndrome. Earlier, he contributed as a lecturer at Ain Shams University (2018–2021) 📚 and as a research assistant and assistant researcher at the National Research Centre (2003–2009). His hands-on lab experience spans molecular cloning, gene editing (CRISPR), microscopy, chromatography, and biophysical techniques, alongside strong teaching and mentoring roles 🔬👨‍🏫.

Awards and Honors

Dr. Taha has an impressive academic journey, starting with a DAAD Scholarship (2009–2014) that provided full funding for his Ph.D. at Heinrich-Heine University, Germany, where he graduated magna cum laude for his exceptional research in biology. He furthered his career with a tenure-track position as a postdoctoral researcher at the National Research Centre in Cairo, followed by an NIH Postdoc Fellowship in the USA (2015–2017). During this time, he also mentored NIH summer students, earning recognition for his guidance. Dr. Taha served as a University Lecturer at Ain Shams University, teaching undergraduate biotechnology from 2018 to 2021. His contributions to neurobiology, proteomics, and molecular diagnostics have earned him a nomination for the Best Researcher Award. His dedication to research and mentoring, coupled with his global academic recognition, showcases his commitment to advancing the scientific community, making him a deserving candidate for further honors and accolades. 🌍🧬📚

Research Focus

Dr. Mohamed Taha’s research bridges molecular biology, neurodegeneration, and proteomics 🧬🧠. His Ph.D. work provided novel insights into Fragile X Mental Retardation Protein (FMRP), a key regulator of neuronal function and synaptic plasticity 💡. At NIH, he advanced proteomic approaches to analyze nuclear pore protein modifications during mitosis 🧫. Currently, he investigates oxidative stress and low-dose radiotherapy as therapeutic strategies for neurodegenerative diseases, especially Alzheimer’s 🧠⚡. He also explores genetic and biochemical markers in autism and viral diseases. His methodologies span CRISPR/Cas9 gene editing, confocal microscopy, flow cytometry, ELISA, FPLC protein purification, and real-time PCR 🔍. With a focus on translational research and early biomarker discovery, Dr. Taha’s work aims to bridge the gap between lab innovations and clinical applications, addressing unmet medical needs and contributing significantly to precision medicine 🌟🧪.

Publication Top Notes

  • Fragile X Messenger Ribonucleoprotein Protein and Its Multifunctionality: From Cytosol to Nucleolus and Back (Biomolecules, 2024)

  • 🦠 In Vitro Assessment of a Natural Monoterpene as an Antiviral Compound against Low Pathogenic Human Coronavirus 229E (Egypt. J. Chem., 2024)

  • 🔄 Physical Interaction between ERas and Arginase-1 in Quiescent Hepatic Stellate Cells (Cells, 2022)

  • 🧪 Telomere Length and Glutathione Level as Potential Biomarkers for Autism (J Psychi Res Rev Rep, 2021)

  • 🔗 Uncovering Multiple Protein Interaction Networks Linked to Fragile X Mental Retardation Protein (FEBS J., 2020)

  • 🛡️ FMRP Protects Against TNF-Mediated Cell Death and Liver Injury (Gut, 2020)

  • 📍 Subcellular Localization Reveals Direct Interaction of FMRP with Nucleolin (Manuscript)

Abimbola Arise | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Abimbola Arise | Biochemistry, Genetics and Molecular Biology | Best Research Article Award

Dr. Abimbola Arise, University of Ilorin, Kwara State, Nigeria

Dr. Abimbola Kemisola Arise (née Jayeoba) is an esteemed researcher and academic in Food Science and Technology. Born on July 5, 1977, she currently serves in the Department of Home Economics and Food Science. She began her academic career as an Assistant Lecturer in 2011 and has since contributed significantly to food research, focusing on food safety, protein characterization, and product development. A dedicated scholar, she has published extensively in international journals and authored book chapters on sensory evaluation and functional food properties. Dr. Arise is a passionate mentor and an active member of multiple professional societies, including the Nigerian Institute of Food Science and Technology (NIFST) and the South African Association for Food Science and Technology. She has also received awards for her outstanding research contributions. Her expertise in food biochemistry and technology continues to impact both academia and industry.

Publication Profile

google scholar

Education 🎓

Dr. Abimbola Kemisola Arise (née Jayeoba) is an esteemed researcher and academic in Food Science and Technology. Born on July 5, 1977, she currently serves in the Department of Home Economics and Food Science. She began her academic career as an Assistant Lecturer in 2011 and has since contributed significantly to food research, with a focus on food safety, protein characterization, and product development. A dedicated scholar, she has published extensively in international journals and authored book chapters on sensory evaluation and functional food properties. Dr. Arise is a passionate mentor and an active member of multiple professional societies, including the Nigerian Institute of Food Science and Technology (NIFST) and the South African Association for Food Science and Technology. She has also received awards for her outstanding research contributions. Her expertise in food biochemistry and technology continues to impact both academia and industry, fostering advancements in nutritional science, product innovation, and food safety standards.

Experience

Dr. Arise has over a decade of experience in academia and food research. She joined the University of Ilorin as an Assistant Lecturer in 2011 and has progressed through the ranks due to her research excellence. Her career has been dedicated to teaching and mentoring students in Food Science and Technology, with a strong emphasis on applied research and industry collaboration.She has led multiple research projects focusing on food safety, functional food development, and protein characterization. Dr. Arise also participates in peer review activities, contributing as a reviewer for reputable scientific journals. Beyond academia, she engages with professional organizations and has presented her findings at international and national conferences.Her experience extends to supervising undergraduate and postgraduate students, developing innovative food products, and collaborating with industry professionals to advance food processing and safety standards in Nigeria and beyond.

Awards & Honors

  • 🥇 Best Poster Presenter Award – NIFST Conference, University of Ilorin (2019)

  • 🎖️ Member, Nigerian Women in Agriculture Research & Development (2019–Present)

  • 🎖️ Member, Nigerian Society of Experimental Biology (NISEB) (2013–Present)

  • 🎖️ Member, South African Association for Food Science and Technology (2014–Present)

  • 🎖️ Member, Nigerian Institute of Food Science and Technology (NIFST) (2011–Present)

Dr. Arise has been recognized for her impactful research, securing the Best Poster Award at the 2019 NIFST Conference. She is a distinguished member of several professional bodies, contributing to advancements in food science through research, mentorship, and collaborations. Her professional affiliations reflect her commitment to scientific excellence and continuous learning in the field.

Research Focus

Dr. Abimbola Kemisola Arise’s research primarily focuses on food biochemistry, functional food development, and protein extraction. She specializes in protein characterization and the functional properties of legumes, particularly exploring alternative protein sources such as Bambara groundnut 🥜. Her work in fortified and enriched food products 🌿 aims to enhance nutritional quality, while her expertise in sensory evaluation and consumer acceptability 🍪 ensures that innovative food products meet consumer preferences. She also investigates food preservation and safety techniques 🧫 to improve shelf life and reduce spoilage. Additionally, her research delves into nutritional profiling and the health benefits of indigenous foods 📉, providing insights into their potential role in public health. Dr. Arise’s studies on Moringa-enriched maize flour, Bambara groundnut proteins, and food storage techniques have contributed significantly to functional food science. She is committed to bridging the gap between scientific innovation and practical food solutions, promoting sustainable food processing technologies to minimize waste and maximize nutrient retention.

Publication Top Notes

📝 Journals

1️⃣ Effects of storage conditions and periods on glycoalkaloids content and nutritional value of Solanum tuberosum – Journal of Agricultural Research and Development (2012)
2️⃣ Acceptability and Nutritional Attributes of Moringa oleifera–enriched maize flour – Journal of Agricultural Research and Development (2012)
3️⃣ The effects of addition of moringa leaf waste fibre on proximate and sensory characteristics of cookies – Agrosearch (2013)
4️⃣ Acceptability and sensory characteristics of moringa leaf and moringa-based species in Kwara State – International Journal of Phytofuel and Allied Sciences (2014)
5️⃣ Proximate composition, functional and sensory properties of “TUWO” from maize and Bambara groundnut – Applied Tropical Agriculture (2019)
6️⃣ Comparative studies on amino acid and functional properties of black benniseed and false sesame protein concentrates – Ajayi Crowther Journal of Pure and Applied Sciences (2024)

📖 Book Chapters

7️⃣ Understanding Sensory Evaluation of Food – Food Science and Technology, Walter De Gruyter STEM (2021)
8️⃣ Bambara Groundnut Protein in Food and Potential Industrial Applications – Springer (2021)

María Rodríguez Pérez | Biochemistry | Best Researcher Award

María Rodríguez Pérez | Biochemistry | Best Researcher Award

María Rodríguez Pérez,UNIVERSIDAD DE CASTILLA LA MANCHA, Spain

María Rodríguez Pérez is a Full Professor of Biochemistry at the University of Castilla-La Mancha, Spain. She was born in 1985 and holds a Researcher ID E-9572-2015 and an ORCID ID 0000-0002-9949-5861. Her research focuses on biochemistry and molecular biology.

Publication Profile

Scopus

Education

María Rodríguez Pérez earned her degree in Biochemistry from the Autonomous University of Madrid in 2008. She then received her Ph.D. in Biochemistry from the University of Castilla-La Mancha in 2014. Her academic background has equipped her with a strong foundation in biochemistry and molecular biology.

Experience

María Rodríguez Pérez has worked as a researcher and professor at the University of Castilla-La Mancha. She has also collaborated with other researchers and institutions, including the University of Cambridge. Her experience has given her expertise in biochemistry, molecular biology, and research.

Awards and Honors

María Rodríguez Pérez has received several awards and honors for her research, including the Premio al mejor trabajo de Investigación Básica sobre Diabetes in 2011 and the Premio “Margarita Lorenzo” in 2016. These awards recognize her contributions to the field of biochemistry and diabetes research.

Research Focus

María Rodríguez Pérez’s research focuses on the molecular mechanisms underlying metabolic diseases, such as diabetes and obesity. She is particularly interested in the role of bioactive compounds, such as polyphenols, in preventing and treating these diseases.

Publications

  1. 🌟 CD38 and ADP-ribosyl cyclase catalyze the synthesis of a dimeric ADP-ribose… (1997)
  2. 🌟 Ectocellular CD38-catalyzed synthesis and intracellular Ca2+-mobilizing activity… (1998)
  3. 🌟 Expression of CD38 increases intracellular calcium concentration and reduces doubling time… (1998)
  4. 🌟 The transmembrane glycoprotein CD38 is a catalytically active transporter… (1998)
  5. 🌟 Dimeric and tetrameric forms of catalytically active transmembrane CD38… (1998)
  6. 🌟 Ligand-induced internalization of CD38 results in intracellular Ca2+ mobilization… (1999)
  7. 🌟 Topology of CD38. (2000)
  8. 🌟 Extracellular cyclic ADP-ribose increases intracellular free calcium concentration… (2000)
  9. 🌟 G(s) protein dysfunction in allergen-challenged human isolated passively sensitized bronchi… (2000)
  10. 🌟 Connexin 43 hemichannels mediate Ca2+-regulated transmembrane NAD+ fluxes… (2001)
  11. 🌟 Extracellular Cyclic ADP-ribose potentiates Ach-induced contraction… (2001)
  12. 🌟 Human CD38 and its ligand CD31 define a unique lamina propria T lymphocyte signaling pathway… (2001)
  13. 🌟 Paracrinally stimulated expansion of early human hemopoietic progenitors… (2001)
  14. 🌟 Paracrine roles of NAD+ and Cyclic ADP-ribose… (2001)
  15. 🌟 Autocrine abscisic acid mediates the UV-B-induced inflammatory response… (2012)
  16. 🌟 Neuroprotective antibiotics in Alzheimer´s disease. (2017)
  17. 🌟 Central s‐resistin deficiency ameliorates hypothalamic inflammation… (2018)
  18. 🌟 Could antibiotics be therapeutic agents in Alzheimer´s Disease? (2018)
  19. 🌟 Effects of moderate chronic food restriction… (2019)
  20. 🌟 Temporal variability measurements of PM2,5 and its associated metals… (2020)
  21. 🌟 Hydroxityrosol improves mitocondrial energetics… (2020)
  22. 🌟 Ageing alters the lipid sensing process… (2021)
  23. 🌟 Are the portable cleaners (PAC) really effective… (2021)
  24. 🌟 Olive oil and wine as source of multi-target agents… (2021)
  25. 🌟 Lactic acid bacteria as biocontrol agents… (2022)
  26. 🌟 Zebrafish Model Insights into Mediterranean Diet Liquids… (2023)
  27. 🌟 Olive oil and wine as source of multi-target agents… (2023)

Lan Wang | Biochemistry | Best Researcher Award

Dr. Lan Wang | Biochemistry | Best Researcher Award

Principal Investigator at Shanghai Institute of Nutrition and Health, China

Dr. Lan Wang is a distinguished researcher specializing in the pathogenesis of hematological malignancies and stem cell studies. She earned her Bachelor’s degree from Fudan University and completed her Ph.D. at the Institute of Health Sciences, Shanghai Institute of Life Science, Chinese Academy of Science. Dr. Wang held notable academic positions at Memorial Sloan-Kettering Cancer Center and the University of Miami before becoming a Principal Investigator at the Shanghai Institute of Nutrition and Health, SINH, CAS. Her research is dedicated to identifying disrupted genes in hematological disorders and developing therapeutic strategies. Dr. Wang has received numerous honors, including the Leukemia Lymphoma Society Fellowship, the Empire State Stem Cell Scholars Fellow to Faculty award, and the China National Funds for Excellent Young Scientists. She holds several patents related to cancer therapies and serves as an editor for Frontiers in Biosciences. Her work significantly contributes to advancing the understanding and treatment of blood-related cancers.

Professional Profiles:

📚 Education:

Dr. Lan Wang received a Bachelor’s degree from Fudan University between 1998 and 2002. Subsequently, from 2002 to 2007, Dr. Wang pursued a Ph.D. at the Institute of Health Sciences, Shanghai Institute of Life Science, Chinese Academy of Science.

Professional Experience:

Dr. Lan Wang held several major academic appointments throughout her career. From 2008 to 2010, she served as a Research Fellow at Memorial Sloan-Kettering Cancer Center. Following this, she was a Research Associate at the same institution from 2010 to 2012. She then became an Assistant Professor in the Department of Biochemistry and Molecular Biology at the Miller School of Medicine, University of Miami, from 2013 to 2015. Since 2015, Dr. Wang has been a Principal Investigator at the Shanghai Institute of Nutrition and Health, SINH, CAS.

Research Interest :

Dr. Lan Wang’s research focuses on understanding the pathogenesis of hematological malignancies and stem cell studies. Specifically, Dr. Wang is interested in identifying the genes disrupted in these disorders and developing new therapeutic strategies for patients with these diseases. Blood cells are generated by hematopoietic stem cells, which are proposed to be the cell of origin in leukemia. Dr. Wang’s research aims to understand how the behavior of these stem cells goes awry when they become transformed. Cancer stem cells exhibit a loss of normal growth control mechanisms, leading to abnormal cell division, survival, and expansion. The development of hematological malignancies is commonly associated with aberrant transcriptional regulation, where genes are inappropriately turned on or off. In most cases, correcting these abnormalities would block the development or progression of hematological malignancies in patients.

Patents :

Dr. Lan Wang holds several patents in the field of therapeutic strategies for cancer treatment. The first patent, co-authored with Nimer SD, is titled “The Novel Therapeutic Strategy for Acute Myeloid Leukemia” with the application number SK2011-037-03, filed in 2011. The second patent, co-authored with Chen Z, Chen SJ, Zhou GB, Liu SC, and Liu P, involves the application of AS4S4/Indigo/Tanshinone IIA for cancer therapy, under the application number 200910051409.5. Another patent, co-authored with Chen SJ, Chen Z, Zhao WL, and Sun HD, covers the application of Eriocalyxin B in pharmacy, with the application number 200510110089.8. The fourth patent, involving Chen Z, Chen SJ, Zhao WL, and Liu YH, is for a medicine combination for the therapy of B-cell lymphoma, with the application number 2005101121147.0.

Awards and Honors:

Dr. Lan Wang has received numerous honors, certificates, and memberships in academic societies throughout her career. In 2005, she was recognized as an Excellent Student by the Chinese Academy of Sciences and received the “Chen Zhu and Chen Saijuan” Award for Outstanding Graduate Student from the Shanghai Institute of Hematology for 2005-2006. In 2009, she was awarded the Leukemia Lymphoma Society Fellowship. She received the American Society of Hematology meeting travel award in 2010 and was appointed as an Associate Faculty Member for the Faculty of 1000 Post-publication peer review in the same year. In 2011, she was honored with the Empire State Stem Cell Scholars Fellow to Faculty award. Dr. Wang became a member of the Sylvester Comprehensive Cancer Center in 2013. From 2014 to 2015, she received several awards, including the Gabrielle’s Angel Foundation for Cancer Research award, The Woman’s Cancer Association of the University of Miami award, and the Leukemia Research Foundation New Investigator award. In 2015, she was granted the Stanley J. Glaser Foundation Award and was a recipient of the Recruitment Program of Global Experts (Young Program). Additionally, she became an Editor of Frontiers in Biosciences. In 2016, Dr. Wang received the China National Funds for Excellent Young Scientists and the Excellent Overseas Returnees Award from the Ministry of Human Resources and Social Security.

📚Publications :

Quantile regression for analyzing heterogeneity in ultra-high dimension

Authors: L. Wang, Y. Wu, R. Li

Journal: Journal of the American Statistical Association

Volume: 107 (497)

Pages: 214-222

Citations: 329

Year: 2012

Quantile-adaptive model-free variable screening for high-dimensional heterogeneous data

Authors: X. He, L. Wang, H.G. Hong

Citations: 289

Year: 2013

Locally weighted censored quantile regression

Authors: H.J. Wang, L. Wang

Journal: Journal of the American Statistical Association

Volume: 104 (487)

Pages: 1117-1128

Citations: 262

Year: 2009

Penalized generalized estimating equations for high-dimensional longitudinal data analysis

Authors: L. Wang, J. Zhou, A. Qu

Journal: Biometrics

Volume: 68 (2)

Pages: 353-360

Citations: 195

Year: 2012

Calibrating non-convex penalized regression in ultra-high dimension

Authors: L. Wang, Y. Kim, R. Li

Journal: Annals of Statistics

Volume: 41 (5)

Pages: 2505

Citations: 192

Year: 2013

Partially linear additive quantile regression in ultra-high dimension

Authors: B. Sherwood, L. Wang

Citations: 140

Year: 2016

A high-dimensional nonparametric multivariate test for mean vector

Authors: L. Wang, B. Peng, R. Li

Journal: Journal of the American Statistical Association

Volume: 110 (512)

Pages: 1658-1669

Citations: 140

Year: 2015

GEE analysis of clustered binary data with diverging number of covariates

Authors: L. Wang

Citations: 121

Year: 2011

An iterative coordinate descent algorithm for high-dimensional nonconvex penalized quantile regression

Authors: B. Peng, L. Wang

Journal: Journal of Computational and Graphical Statistics

Volume: 24 (3)

Pages: 676-694

Citations: 96

Year: 2015

Weighted Wilcoxon-type smoothly clipped absolute deviation method

Authors: L. Wang, R. Li

Journal: Biometrics

Volume: 65 (2)

Pages: 564-571

Citations: 80

Year: 2009